申请人:Adcock Claire
公开号:US20090215776A1
公开(公告)日:2009-08-27
Compounds of formula I
in free or salt or solvate form, where T
1
, T
2
, X, R
a
, R
b
, R
8
and R
9
have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
式I的化合物以自由形式、盐形式或溶剂合形式存在,其中T1、T2、X、Ra、Rb、R8和R9的含义如规范中所示,可用于治疗炎症或阻塞性气道、肺动脉高压、肺纤维化、肝纤维化、肌肉疾病和全身骨骼疾病。还描述了含有这些化合物的药物组合物和制备这些化合物的方法。